• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[梅克伦堡-前波美拉尼亚州的宫颈癌。985例患者的肿瘤分期、组织学肿瘤类型、年龄及筛查参与情况]

[Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].

作者信息

Marquardt K, Stubbe M, Broschewitz U

机构信息

Praxis für Pathologie, Güstrower Str. 34, 19055, Schwerin, Deutschland.

Praxis für Pathologie, Rostock, Deutschland.

出版信息

Pathologe. 2016 Feb;37(1):78-83. doi: 10.1007/s00292-015-0120-1.

DOI:10.1007/s00292-015-0120-1
PMID:26660458
Abstract

BACKGROUND

In view of the discussion on primary human papillomavirus (HPV) screening it was necessary to evaluate recent and reliable data from the current cytology-based screening program.

METHODS

Since the year 2004 all cases of cervical cancer must be reported to the Joint State Quality Control Commission in Mecklenburg-Western Pomerania, corrected and supplemented by data of the State Cancer Registry. The screening histories of all patients, age, tumor stages and histological tumor types were analyzed.

RESULTS

Over a 10-year period (2004-2013) 985 women with invasive cervical cancer and complete data were identified, of whom 573 patients (58 %) had not had a cervical smear within the past 5 years, an irregular screening history was found in 312 patients (32 %) and 100 patients (10 %) had cervical cancer despite regular participation. In women who did not participate in the screening program, tumor stages T1b and higher were found in 85 %. In the group of women with regular screening 53 % were diagnosed with microinvasive cancer and in 38 % of women with irregular screening. The age distribution showed a peak for cervical cancer in the age group of 40-54 years. Squamous cell carcinoma dominated and adenocarcinoma was found in 17 % which showed a tendency to increase over the investigation time period.

CONCLUSION

Most cervical cancers and the advanced stages were found in women who did not participate in the screening program.

摘要

背景

鉴于关于原发性人乳头瘤病毒(HPV)筛查的讨论,有必要评估当前基于细胞学的筛查项目的最新可靠数据。

方法

自2004年起,所有宫颈癌病例必须上报至梅克伦堡-前波美拉尼亚州联合国家质量控制委员会,并由国家癌症登记处的数据进行校正和补充。分析了所有患者的筛查史、年龄、肿瘤分期和组织学肿瘤类型。

结果

在10年期间(2004 - 2013年),共确定了985例患有浸润性宫颈癌且数据完整的女性,其中573例患者(58%)在过去5年内未进行过宫颈涂片检查,312例患者(32%)筛查史不规律,100例患者(10%)尽管定期参与筛查仍患宫颈癌。未参加筛查项目的女性中,85%的肿瘤分期为T1b及以上。在定期筛查的女性组中,53%被诊断为微浸润癌,在筛查不规律的女性组中这一比例为38%。年龄分布显示,宫颈癌在40 - 54岁年龄组出现一个高峰。鳞状细胞癌占主导,腺癌占17%,且在调查期间有增加趋势。

结论

大多数宫颈癌及晚期病例发现于未参加筛查项目的女性中。

相似文献

1
[Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].[梅克伦堡-前波美拉尼亚州的宫颈癌。985例患者的肿瘤分期、组织学肿瘤类型、年龄及筛查参与情况]
Pathologe. 2016 Feb;37(1):78-83. doi: 10.1007/s00292-015-0120-1.
2
Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.斯洛文尼亚国家宫颈癌筛查计划开展3年后,对浸润性宫颈癌女性患者的阴性及低级别宫颈涂片检查结果进行回顾。
Cytopathology. 2012 Feb;23(1):23-9. doi: 10.1111/j.1365-2303.2010.00816.x. Epub 2010 Oct 21.
3
Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.287 例宫颈鳞癌女性的癌症诊断相关筛查试验结果。
Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.
4
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.筛查频率和组织学类型影响宫颈癌筛查效果:一项全国性队列研究。
Taiwan J Obstet Gynecol. 2017 Aug;56(4):442-448. doi: 10.1016/j.tjog.2017.01.010.
5
Review of the screening history of Alberta women with invasive cervical cancer.对艾伯塔省浸润性宫颈癌女性筛查史的回顾。
CMAJ. 1997 Sep 1;157(5):513-9.
6
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.浸润性宫颈癌发生前人类乳头瘤病毒DNA的型特异性持续性
N Engl J Med. 1999 Nov 25;341(22):1633-8. doi: 10.1056/NEJM199911253412201.
7
About invasive cervical cancer: a French population based study between 1998 and 2010.关于浸润性宫颈癌:一项基于1998年至2010年法国人群的研究。
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:1-6. doi: 10.1016/j.ejogrb.2015.04.007. Epub 2015 May 12.
8
Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause.宫颈癌筛查中的持续性癌:未参与是最主要原因。
Acta Cytol. 2011;55(5):433-7. doi: 10.1159/000331811. Epub 2011 Oct 8.
9
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
10
History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.中国最大的妇女医院的经验:一大群浸润性宫颈癌患者的高危人乳头瘤病毒感染史和巴氏试验结果
Cancer Cytopathol. 2015 Jul;123(7):421-7. doi: 10.1002/cncy.21545. Epub 2015 May 8.

引用本文的文献

1
Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.德国机会性筛查对宫颈鳞癌和腺癌的影响:一项基于人群的病例对照研究。
PLoS One. 2021 Jul 14;16(7):e0253801. doi: 10.1371/journal.pone.0253801. eCollection 2021.
2
The effect of Pap smear screening on cervical cancer stage among southern Thai women.巴氏涂片筛查对泰国南部女性宫颈癌分期的影响。
Sci Rep. 2019 Nov 15;9(1):16921. doi: 10.1038/s41598-019-52607-6.
3
[Squamous cell precancerous lesions of the cervix uteri].

本文引用的文献

1
Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content.参与乳腺钼靶筛查的意愿:一项关于对两份内容不同的患者信息传单的反应的随机对照问卷调查研究。
Dtsch Arztebl Int. 2015 Jan 30;112(5):61-8. doi: 10.3238/arztebl.2015.0061.
2
Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause.宫颈癌筛查中的持续性癌:未参与是最主要原因。
Acta Cytol. 2011;55(5):433-7. doi: 10.1159/000331811. Epub 2011 Oct 8.
3
Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.
子宫颈鳞状上皮细胞癌前病变
Pathologe. 2019 Feb;40(1):7-12. doi: 10.1007/s00292-018-0561-4.
4
[The new S3 guideline "Prevention of cervical carcinoma" : What is important for pathology?].[新的S3指南“宫颈癌的预防”:对病理学而言什么是重要的?]
Pathologe. 2018 May;39(3):269-279. doi: 10.1007/s00292-018-0441-y.
5
[Screening for cervical and breast cancer].[宫颈癌和乳腺癌筛查]
Pathologe. 2016 Sep;37(5):477-89. doi: 10.1007/s00292-016-0228-y.
人乳头瘤病毒疫苗接种时代宫颈癌预防筛查:澳大利亚视角
Acta Cytol. 2011;55(4):307-12. doi: 10.1159/000326956. Epub 2011 Jul 22.
4
Routine audit of large-scale cervical cancer screening programs.大规模宫颈癌筛查项目的常规审计
J Natl Cancer Inst. 2008 May 7;100(9):605-6. doi: 10.1093/jnci/djn131. Epub 2008 Apr 29.
5
[Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].
Pathologe. 2007 Sep;28(5):339-45. doi: 10.1007/s00292-007-0931-9.
6
Incidence trends of adenocarcinoma of the cervix in 13 European countries.13个欧洲国家子宫颈腺癌的发病率趋势
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2191-9. doi: 10.1158/1055-9965.EPI-05-0231.
7
Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.细胞学筛查对腺癌的保护作用较低,对年轻女性的保护作用持续时间较短:佛罗伦萨一项病例对照研究的结果。
Br J Cancer. 2004 May 4;90(9):1784-6. doi: 10.1038/sj.bjc.6601754.
8
Cervical cytologic smear false negative fraction. Reduction in a small community hospital.宫颈细胞学涂片假阴性率。一家小型社区医院的降低情况。
Acta Cytol. 1997 Nov-Dec;41(6):1690-6. doi: 10.1159/000333169.